Search research articles
Contact Us
Filters
Showing results (311-320 of 330) with videos related to
Page
of 33
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2023
Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study
Herbert L Duvivier, Michael Rothe, Pam K Mangat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 24, 2018
Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic Gliomas
Antonio Omuro, Kathryn Beal, Katharine McNeill, et al.
Clinical Pharmacology and Therapeutics
|
October 19, 2021
The Friends of Cancer Research Real-World Data Collaboration Pilot 2.0: Methodological Recommendations from Oncology Case Studies
Donna R Rivera, Henry J Henk, Elizabeth Garrett-Mayer, et al.
JCO Precision Oncology
|
October 16, 2024
Palbociclib in Patients With Head and Neck Cancer and Other Tumors With <i>CDKN2A</i> Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study
Francis P Worden, Evan Pisick, Michael Rothe, et al.
Cancer Immunology, Immunotherapy : CII
|
December 22, 2017
Correction to: Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells
Tamson Moore, Courtney Regan Wagner, Gina M Scurti, et al.
Breast Cancer Research and Treatment
|
October 29, 2018
Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention
Katherine R Walter, Marvella E Ford, Mathew J Gregoski, et al.
Cell Reports. Medicine
|
November 10, 2021
Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma
Hannah M Knochelmann, Joshua D Horton, Sixue Liu, et al.
JCO Precision Oncology
|
April 22, 2026
Temsirolimus in Patients With Solid Tumors With <i>PIK3CA</i> Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Evan Pisick, Michael Rothe, Elizabeth Garrett-Mayer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 27, 2021
A Grant-Based Experiment to Train Clinical Investigators: The AACR/ASCO Methods in Clinical Cancer Research Workshop
Daniel D Von Hoff, Gary M Clark, Charles A Coltman, et al.
Cancer Immunology, Immunotherapy : CII
|
October 21, 2017
Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells
Tamson Moore, Courtney Regan Wagner, Gina M Scurti, et al.
Page
of 33
Search research articles
Search
Showing results (311-320 of 330) with videos related to
Sort By:
Page
of 33
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2023
Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study
Herbert L Duvivier, Michael Rothe, Pam K Mangat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 24, 2018
Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic Gliomas
Antonio Omuro, Kathryn Beal, Katharine McNeill, et al.
Clinical Pharmacology and Therapeutics
|
October 19, 2021
The Friends of Cancer Research Real-World Data Collaboration Pilot 2.0: Methodological Recommendations from Oncology Case Studies
Donna R Rivera, Henry J Henk, Elizabeth Garrett-Mayer, et al.
JCO Precision Oncology
|
October 16, 2024
Palbociclib in Patients With Head and Neck Cancer and Other Tumors With <i>CDKN2A</i> Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study
Francis P Worden, Evan Pisick, Michael Rothe, et al.
Cancer Immunology, Immunotherapy : CII
|
December 22, 2017
Correction to: Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells
Tamson Moore, Courtney Regan Wagner, Gina M Scurti, et al.
Breast Cancer Research and Treatment
|
October 29, 2018
Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention
Katherine R Walter, Marvella E Ford, Mathew J Gregoski, et al.
Cell Reports. Medicine
|
November 10, 2021
Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma
Hannah M Knochelmann, Joshua D Horton, Sixue Liu, et al.
JCO Precision Oncology
|
April 22, 2026
Temsirolimus in Patients With Solid Tumors With <i>PIK3CA</i> Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Evan Pisick, Michael Rothe, Elizabeth Garrett-Mayer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 27, 2021
A Grant-Based Experiment to Train Clinical Investigators: The AACR/ASCO Methods in Clinical Cancer Research Workshop
Daniel D Von Hoff, Gary M Clark, Charles A Coltman, et al.
Cancer Immunology, Immunotherapy : CII
|
October 21, 2017
Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells
Tamson Moore, Courtney Regan Wagner, Gina M Scurti, et al.
Page
of 33